Home
Novartis

Novartis Market Share Analysis for July 2026

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.

Health > Biotechnology and Pharmaceuticals

Domainnovartis.it

Year Founded1996

Employees> 10001

Annual Revenue> $1B

Novartis

Novartis (including company regionals)

novartis.it

See more website traffic and engagement information

Novartis Revenue up to July 2026 is > 1B

revenue generated by Novartis top domains

Novartis top domains revenue over 3 years

Revenue for Novartis top domains

novartis.it> 1B

See more with Sales Intelligence

Novartis Stock price in July 2026

Novartis stock is traded under the ticker #NVS. Below you can review Novartis stock performance in the past 12 months up to July 2026

Total visits to Novartis's top domains

Understand Novartis market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Novartis's top domains

Analyze Novartis engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Novartis's top domains

See how Novartis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Novartis top competitors by domain

Top similar sites in July 2026, ranked by their affinity

sanofi.itCompany NameSanofiEmployees> 10001HQFrance, ParisAnnual revenue> $1BTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Novartis

These are the website technologies, by industry, used by Novartis top domains

Advertising (9)

DoubleClick

Social (5)

Instagram

Conversion & Analytics (4)

Google Analytics

Widget (4)

reCAPTCHA

More Technologies

8

See all

News & Signals from Novartis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNovartis acquires Gyroscopetx for $1.5B.read more ** Novartis (NOVN.S) is buying Gyroscope Therapeutics for up to $1.5 billion, as the Swiss drugmaker looks to bolster its gene therapy roster with the British firm's treatment for an eye condition that can cause blindness.

NewsNovartis acquired Advanced Accelerator Applications S.A on Jan 1st '17.For instance, in 2017, Novartis acquired Advanced Accelerator Applications.